Mannitol moa
Mannitol is an osmotic agent - it draws water from tissues into the bloodstream by creating an osmotic gradient. In the brain, it reduces intracranial pressure by pulling fluid out of cerebral tissue across the blood-brain barrier. It also acts as an osmotic diuretic in the kidneys, preventing water reabsorption in the tubules.
Searching sources...
Reading File
Finding Sources
Searching the Web
mannitol mechanism of action pharmacology ICP osmotic diuretic
Reading File
Finding Sources
Reading File
Reading File
Here is a detailed breakdown of mannitol's mechanism of action, drawn from multiple pharmacology and physiology textbooks:
Mannitol - Mechanism of Action
What is Mannitol?
Mannitol is a six-carbon sugar alcohol (reduced fructose) that is the prototypic osmotic diuretic. It is given intravenously because oral administration causes osmotic diarrhea rather than diuresis.
Core Mechanism: Osmotic Action
Mannitol works by being an osmotically active, non-reabsorbable solute. Because it is:
- Freely filtered at the glomerulus
- Not metabolized
- Poorly/not reabsorbed in the renal tubules
...it exerts its effects purely through osmotic forces.
1. Osmotic Diuresis (Renal Mechanism)
Site of action: Proximal tubule + descending limb of loop of Henle + collecting duct
- Filtered mannitol accumulates in the proximal tubule and descending limb, which are normally freely permeable to water.
- The presence of this non-reabsorbable solute creates a countervailing osmotic force that opposes normal passive water reabsorption.
- Ongoing Na+ reabsorption lowers tubular fluid [Na+], creating a gradient for back-flux of reabsorbed Na+ into the tubule - impairing net sodium reabsorption.
- The same mechanism impairs water and solute reabsorption in the loop of Henle.
- Mannitol also opposes ADH action in the collecting tubule via osmotic effects.
- Net result: large water diuresis > natriuresis (leads to hypernatremia if free water not replaced).
(Morgan & Mikhail's Clinical Anesthesiology; Katzung's Basic & Clinical Pharmacology; Brenner & Rector's The Kidney)
2. Reduction of Intracranial Pressure (ICP)
Mechanism - osmotic gradient across the BBB:
- IV mannitol raises plasma osmolality, creating an osmotic gradient between the blood and the brain.
- Water moves out of cerebral tissue (across the relatively intact blood-brain barrier) into the intravascular compartment.
- This reduces brain water content and cell volume, lowering ICP.
- Intracranial pressure falls within 60-90 minutes of administration.
- Dose: 0.25-1 g/kg IV (Morgan & Mikhail); 1-2 g/kg (Katzung) as 15-20% solution.
(Katzung; Morgan & Mikhail)
3. Reduction of Intraocular Pressure
- Same osmotic principle applies to the aqueous humor of the eye.
- Mannitol extracts water from the vitreous/aqueous compartment, reducing intraocular pressure.
- Used perioperatively in ophthalmologic procedures.
4. Additional Mechanisms
| Mechanism | Effect |
|---|---|
| Increases renal blood flow (RBF) | Via hemodilution + decreased hematocrit/viscosity |
| Activates intrarenal prostaglandin synthesis | Vasodilation, contributing to increased RBF |
| Decreases medullary solute gradient | Prevents urinary concentration |
| Free radical scavenging | Proposed role in renal protection |
| BBB disruption (high-dose intra-arterial) | Transiently opens tight junctions in brain endothelium - used experimentally for drug delivery |
(Brenner & Rector; Morgan & Mikhail; Goodman & Gilman)
Pharmacokinetics Summary
| Parameter | Detail |
|---|---|
| Route | IV only (oral = osmotic diarrhea) |
| Distribution | Extracellular fluid only |
| Metabolism | Not metabolized |
| Elimination | Glomerular filtration; t½ ~1 hour (normal), up to 36 hours in severe CKD |
Key Clinical Uses
- Raised ICP (traumatic brain injury, cerebral edema)
- Raised intraocular pressure (pre-operative ophthalmology)
- Acute kidney injury - to promote diuresis, flush tubular toxins
- Dialysis disequilibrium syndrome - can reverse it
- Ciguatera fish poisoning - reduces Schwann cell edema
Important Adverse Effects
- Before diuresis: Expands ECF - can precipitate pulmonary edema in heart failure
- After diuresis: Dehydration, hypernatremia, hyperkalemia, metabolic acidosis
- High doses: Nephrotoxicity (especially in pre-existing renal impairment)
- Headache, nausea, vomiting
Contraindicated in anuria, severe heart failure, and active intracranial bleeding (paradoxical ICP rise if BBB disrupted).
This is a shared conversation. Sign in to Orris to start your own chat.